Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy

Journal of the American Society of Nephrology

Volumn 24, Issue 5, 2013, Pages 722-725

  Larsen, Christopher P ^a,b   Beggs, Marjorie L ^a   Saeed, Mohammad ^a   Walker, Patrick D ^a,b  

^a Nephropath   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; DNA; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; ARTICLE; COLLAPSING GLOMERULOPATHY; DNA EXTRACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84877094422     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012121180     Document Type: Article

References (20)

1. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996 (Pubitemid 26364283)
2. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 56: 2203-2213, 1999 (Pubitemid 30004749)
3. Albaqumi M, Barisoni L: Current views on collapsing glomerulopathy. J Am Soc Nephrol 19: 1276-1281, 2008
4. Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV: Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol 7: 914-925, 2012
5. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
6. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345-350, 2010
7. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
8. Haas M, Kaul S, Eustace JA: HIV-associated immune complex glomerulonephritis with "lupus-like" features: A clinicopathologic study of 14 cases. Kidney Int 67: 1381-1390, 2005 (Pubitemid 40463114)
9. D'Agati VDD, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 8: 138-152, 1997
10. Rich SA: De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon. J Clin Invest 95: 219-226, 1995
11. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD: Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5: 607-615, 2010
12. Schwimmer JA, Markowitz GS, Valeri AM, Appel GB: Collapsing glomerulopathy. Semin Nephrol 23: 209-218, 2003 (Pubitemid 36397103)
13. Haas M: Collapsing glomerulopathy in systemic lupus erythematosus: An extreme form of lupus podocytopathy? Clin J Am Soc Nephrol 7: 878-880, 2012
14. Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, Park SY, Bang SY, Song YW, Boackle SA, Brown EE, Edberg JC, Alarcón GS, Petri MA, Criswell LA, Ramsey-Goldman R, Reveille JD, Vila LM, Gilkeson GS, Kamen DL, Ziegler J, Jacob CO, Rasmussen A, James JA, Kimberly RP, Merrill JT, Niewold TB, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Moser KL, Harley JB, Gaffney PM, Montgomery CG; BIOLUPUS and GENLES Networks: Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun 13: 232-238, 2012
15. Albaqumi M, Soos TJ, Barisoni L, Nelson PJ: Collapsing glomerulopathy. J Am Soc Nephrol 17: 2854-2863, 2006 (Pubitemid 44484675)
16. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E: HIV-associated kidney glomerular diseases: Changes with time and HAART. Nephrol Dial Transplant 27: 2349-2355, 2012
17. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18: 541-546, 2004 (Pubitemid 38365883)
18. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004 (Pubitemid 38146337)
19. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classi fication of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004 (Pubitemid 38140764)
20. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE: Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75: 382-391, 1983 (Pubitemid 13005770)